Search Results
Search for other papers by Rafaella Sales de Freitas in
Google Scholar
PubMed
Search for other papers by Thiago F A França in
Google Scholar
PubMed
Search for other papers by Sabine Pompeia in
Google Scholar
PubMed
involves neuroendocrine changes leading to maturation of the gonads, acceleration of growth in height, and development of secondary sexual characteristics. The kisspeptin peptides, produced by small groups of neurons in the hypothalamus, play a key role in
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
development of internal and external reproductive organs and secondary sexual characteristics before the age of 8 in girls and 9 in boys ( 1 ). In recent years, the age of puberty initiation has been declining all over the world, paralleled by the increasing
Search for other papers by Amar Osmancevic in
Google Scholar
PubMed
Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed
Search for other papers by Margareta Hellgren in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
Search for other papers by Bledar Daka in
Google Scholar
PubMed
. ( https://doi.org/10.2164/jandrol.111.015065 ) 27 Tajar A Forti G O’Neill TW Lee DM Silman AJ Finn JD Bartfai G Boonen S Casanueva FF Giwercman A , Characteristics of secondary, primary, and compensated hypogonadism in aging men
Search for other papers by Silvia Ciancia in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
youth healthcare. Current guidelines recommend the use of GnRH analogs (GnRHa) to suppress puberty and prevent the development of secondary sexual characteristics. At ages 15–16 years, gender-affirming hormones (GAH) are usually added (non
Search for other papers by Sebastian Franik in
Google Scholar
PubMed
Search for other papers by Kathrin Fleischer in
Google Scholar
PubMed
Search for other papers by Barbara Kortmann in
Google Scholar
PubMed
Search for other papers by Nike M Stikkelbroeck in
Google Scholar
PubMed
Search for other papers by Kathleen D’Hauwers in
Google Scholar
PubMed
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
Search for other papers by Jolanta Slowikowska-Hilczer in
Google Scholar
PubMed
Search for other papers by Solange Grunenwald in
Google Scholar
PubMed
Search for other papers by Tim van de Grift in
Google Scholar
PubMed
Search for other papers by Audrey Cartault in
Google Scholar
PubMed
Search for other papers by Annette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Ute Thyen in
Google Scholar
PubMed
Search for other papers by Joanna IntHout in
Google Scholar
PubMed
Search for other papers by Hedi L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by the dsd-LIFE Group in
Google Scholar
PubMed
azoospermia is found in about 90% of adult men with KS ( 2 ). Other frequent clinical symptoms include gynecomastia, a low sexual drive, small testes and hypogonadism due to impaired testosterone production ( 3 , 4 ). KS is also associated with
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Brendan J Nolan in
Google Scholar
PubMed
Search for other papers by Aviva S Frydman in
Google Scholar
PubMed
Search for other papers by Shalem Y Leemaqz in
Google Scholar
PubMed
Search for other papers by Meg Carroll in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
development of physical characteristics that align with their gender identity and improves mental health ( 1 ). There has been an ongoing debate regarding the inclusion of progesterone in feminising hormone therapy regimens. Some suggest progesterone may aid
Department of Performance and Image-enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands
Search for other papers by Peter Bond in
Google Scholar
PubMed
Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands
Search for other papers by Tijs Verdegaal in
Google Scholar
PubMed
Department of Performance and Image-enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands
Search for other papers by Diederik L Smit in
Google Scholar
PubMed
König CS Balabani S Hackett GI Strange RC & Ramachandran S . Testosterone therapy: an assessment of the clinical consequences of changes in hematocrit and blood flow characteristics . Sexual Medicine Reviews 2019 7 650 – 660 . ( https
Search for other papers by Giuseppe Grande in
Google Scholar
PubMed
Search for other papers by Andrea Graziani in
Google Scholar
PubMed
Search for other papers by Antonella Di Mambro in
Google Scholar
PubMed
Search for other papers by Riccardo Selice in
Google Scholar
PubMed
Department of Medicine, University of Padova, Padova, Italy
Search for other papers by Alberto Ferlin in
Google Scholar
PubMed
measuring the trabecular bone score (TBS), a parameter which is related to the 3D features of the bone and the trabecular characteristics. TBS is a measurement of the variation in gray-level texture between adjacent pixels in two-dimensional projection